ACSL4 and cancer: However, the Janus-faced role of ACSL4 in cancers due to the diverse pathophysiology of cancers and the heterogeneous nature of tumors, make the lack of consistency becomes a problem to evaluate the indicative effect of biomarker ACSL4.